What is Zacks Research’s Estimate for Teleflex Q2 Earnings?

Teleflex Incorporated (NYSE:TFX) – Analysts at Zacks Research lowered their Q2 2025 earnings estimates for shares of Teleflex in a research report issued to clients and investors on Thursday, March 6th. Zacks Research analyst R. Department now anticipates that the medical technology company will earn $3.36 per share for the quarter, down from their previous forecast of $3.71. The consensus estimate for Teleflex’s current full-year earnings is $13.98 per share. Zacks Research also issued estimates for Teleflex’s Q3 2025 earnings at $3.74 EPS, Q4 2025 earnings at $4.17 EPS, Q2 2026 earnings at $3.77 EPS, Q3 2026 earnings at $3.94 EPS, Q4 2026 earnings at $3.80 EPS and FY2027 earnings at $14.39 EPS.

TFX has been the topic of several other reports. Royal Bank of Canada lowered shares of Teleflex from an “outperform” rating to a “sector perform” rating and lowered their target price for the stock from $220.00 to $155.00 in a research note on Friday, February 28th. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. Truist Financial decreased their price target on shares of Teleflex from $200.00 to $149.00 and set a “hold” rating on the stock in a research note on Monday, March 3rd. Bank of America lowered shares of Teleflex from a “neutral” rating to an “underperform” rating and decreased their price target for the company from $235.00 to $140.00 in a research note on Tuesday. Finally, Raymond James lowered shares of Teleflex from an “outperform” rating to a “market perform” rating in a research note on Friday, February 28th. One analyst has rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, Teleflex presently has an average rating of “Hold” and an average price target of $182.63.

Teleflex Trading Up 2.9 %

TFX stock opened at $140.24 on Friday. The company’s 50-day simple moving average is $171.13 and its 200-day simple moving average is $201.55. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. Teleflex has a 52-week low of $128.55 and a 52-week high of $249.90. The firm has a market cap of $6.50 billion, a P/E ratio of 27.88, a PEG ratio of 1.73 and a beta of 1.21.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The business had revenue of $795.40 million for the quarter, compared to analyst estimates of $813.24 million.

Teleflex Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Friday, March 7th will be paid a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 0.97%. The ex-dividend date is Friday, March 7th. Teleflex’s dividend payout ratio (DPR) is 95.77%.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. Siemens Fonds Invest GmbH purchased a new position in Teleflex in the 4th quarter worth approximately $1,336,000. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Teleflex in the 4th quarter worth approximately $6,528,000. Jefferies Financial Group Inc. lifted its stake in Teleflex by 9.3% in the 4th quarter. Jefferies Financial Group Inc. now owns 4,837 shares of the medical technology company’s stock worth $861,000 after purchasing an additional 412 shares in the last quarter. Mackenzie Financial Corp increased its holdings in shares of Teleflex by 59.2% during the 4th quarter. Mackenzie Financial Corp now owns 36,281 shares of the medical technology company’s stock worth $6,457,000 after buying an additional 13,488 shares during the last quarter. Finally, Forum Financial Management LP increased its holdings in shares of Teleflex by 48.6% during the 4th quarter. Forum Financial Management LP now owns 1,293 shares of the medical technology company’s stock worth $230,000 after buying an additional 423 shares during the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.